FeesSafety
Pluang+

Prenetics' IM8 Q3 revenue soars 266% YoY, reaffirms $220–230M 2026 guidance and $400M+ 2027 target

Company Fundamentals
18 Nov 2026, 15:01 WIB
GlobeNewsWire
View Source
Bullish
Prenetics' IM8 Q3 revenue soars 266% YoY, reaffirms $220–230M 2026 guidance and $400M+ 2027 target

Prenetics Global Limited reported a 266% year-over-year revenue increase for its IM8 brand in Q3 2026, reaching $62.9 million and surpassing guidance. The company reaffirmed its full-year 2026 revenue guidance of $220–230 million and expects IM8 revenue to exceed $400 million in 2027. Despite a loss of $25.4 million this quarter, adjusted EBITDA loss improved and the company generated positive adjusted free cash flow. Prenetics plans to increase investment in customer acquisition, supported by strong customer returns and a solid cash position of $111.5 million as of September 2026.

Prenetics’ IM8 brand revenue growth is the subject, with Pluang market data providing context as of Nov 18, 2026 19:21 WIB: among 150 priced Health-sector US stocks tradable on Pluang, 55 rose and 86 fell today. Notable movers include SLS at USD 18.61 with a 1-day change of -2.82% and a near-even Pluang order activity split, LQDA at USD 55.19 down 2.71% with 100% sell orders, and RXRX at USD 2.79 up 2.57% but mostly sell orders. The most notable figure is LQDA’s full sell order activity on Pluang.

More News

Lowe's beats Q3 earnings estimates and raises full-year sales outlook.

Lowe's beats Q3 earnings estimates and raises full-year sales outlook.

Lowe's reported adjusted earnings per share of $3.10, surpassing estimates of $2.88, and revenue of $22.80 billion, beating the $22.40 billion forecast. Comparable sales rose 1.8%, driven by strong online and professional services sales. The company ...

Company Fundamentals
Bullish
49 minutes ago
Major Memphis health system expands Daxor's blood volume testing to new outpatient site with 24-hour results.

Major Memphis health system expands Daxor's blood volume testing to new outpatient site with 24-hour results.

Daxor Corporation announced that a major Memphis health system has expanded its Blood Volume Analysis (BVA) program to an additional hospital outpatient site using Daxor’s ezBVA Lab service. This expansion allows the outpatient clinic to receive bloo...

Market News
Bullish
54 minutes ago
Microsoft shares drop 2.27% after global outages despite Oppenheimer's Outperform rating

Microsoft shares drop 2.27% after global outages despite Oppenheimer's Outperform rating

Microsoft's stock fell 2.27% to $506.24 following global outages affecting its Copilot, Teams, and Outlook services. The outages, attributed to server issues rather than cyberattacks, raised concerns amid broader software sector weakness. Oppenheimer...

Market News
Bearish
1 hour ago
Target posts strongest sales growth in 5 years, raises annual sales growth target to 6%.

Target posts strongest sales growth in 5 years, raises annual sales growth target to 6%.

Target Corporation reported earnings per share of $2.65, beating estimates of $2.08, and revenue of $27.1 billion, surpassing the $26.5 billion forecast. The company achieved its strongest quarterly sales growth in about five years, with net sales up...

Company Fundamentals
Bullish
1 hour ago
Aquestive Therapeutics to present at Piper Sandler Healthcare Conference on Dec 2, 2026

Aquestive Therapeutics to present at Piper Sandler Healthcare Conference on Dec 2, 2026

Aquestive Therapeutics announced its participation in the Piper Sandler 38th Annual Healthcare Conference from December 1-3, 2026, in New York City. CEO Daniel Barber will present on December 2 at 10:30 am ET, with one-on-one investor meetings schedu...

Market News
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App